Back
Editas Medicine Stock Price Chart
MarketBeat Alert: Escape the market madness with 7 stocks to buy and hold
The result is a select group of high-quality blue-chip stocks.
Sell
37
EDIT
Editas Medicine
Last Price:
5.62
Seasonality Move:
4.23%
7 Day Trial
ALL ACCESS PASS
$
7
America's Final Republican President
Click here to see his 2024 election prediction.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EDIT is experiencing buying pressure, which is a positive indicator for future bullish movement.
Editas Medicine Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.38 | Buy |
| 20-day SMA: | 5.86 | Sell |
| 50-day SMA: | 7.32 | Sell |
| 200-day SMA: | 8.25 | Sell |
| 8-day EMA: | 5.48 | Buy |
| 20-day EMA: | 5.89 | Sell |
| 50-day EMA: | 6.81 | Sell |
| 200-day EMA: | 8.26 | Sell |
Editas Medicine Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.53 | Sell |
| Relative Strength Index (14 RSI): | 37.94 | Sell |
| Chaikin Money Flow: | 1109907 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.38 - 6.8) | Sell |
| Bollinger Bands (100): | (6.49 - 9.67) | Sell |
Editas Medicine Technical Analysis
| Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Editas Medicine Stock
Is Editas Medicine Stock a Buy?
- Editas Medicine share price is 5.62 while EDIT 8-day simple moving average is 5.38, which is a Buy signal.
- The stock price of EDIT is 5.62 while Editas Medicine 20-day SMA is 5.86, which makes it a Sell.
- Editas Medicine 50-day simple moving average is 7.32 while EDIT share price is 5.62, making it a Sell technically.
- EDIT stock price is 5.62 and Editas Medicine 200-day simple moving average is 8.25, creating a Sell signal.
EDIT Technical Analysis vs Fundamental Analysis
Sell
37
Editas Medicine (EDIT)
is a Sell
Is Editas Medicine a Buy or a Sell?
-
Editas Medicine stock is rated a Sell
The current Editas Medicine [EDIT] share price is $5.62. The Score for EDIT is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
Editas Medicine Stock Info
Market Cap:
459.79M
Price in USD:
5.62
Share Volume:
1.34M
Editas Medicine 52-Week Range
52-Week High:
11.91
52-Week Low:
5.11
Sell
37
Editas Medicine (EDIT)
is a Sell
Editas Medicine Share Price Forecast
-
What is the Editas Medicine stock price today?
The Editas Medicine stock price is 5.62 USD today. -
Will EDIT stock go up or go down?
Editas Medicine> share price is forecast to RISE/FALL based on technical indicators -
Is Editas Medicine overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Editas Medicine is overvalued.
Is Editas Medicine Stock a Buy?
- Editas Medicine share price is 5.62 while EDIT 8-day exponential moving average is 5.48, which is a Buy signal.
- The stock price of EDIT is 5.62 while Editas Medicine 20-day EMA is 5.89, which makes it a Sell.
- Editas Medicine 50-day exponential moving average is 6.81 while EDIT share price is 5.62, making it a Sell technically.
- EDIT stock price is 5.62 and Editas Medicine 200-day simple moving average is 8.26, creating a Sell signal.
Fundamental Analysis of Editas Medicine
Is Editas Medicine a good investment?
- Analysts estimate an earnings decrease this quarter of $0.13 per share, an increase next quarter of $0.08 per share, a decrease this year of $0.34 per share, and a decrease next year of $0.17 per share.
Technical Analysis of Editas Medicine
Should I short Editas Medicine stock?
- EDIT Moving Average Covergence Divergence (MACD) indicator is -0.53, suggesting Editas Medicine is a Sell
- Editas Medicine Relative Strength Index (RSI) is 37.94, which suggest Editas Medicine is oversold
- The Bollinger Bands (25) for Editas Medicine is (5.38 - 6.8), which suggest Editas Medicine is a Sell
- The Bollinger Bands (100) for Editas Medicine is (6.49 - 9.67), which suggest Editas Medicine is a Sell
* Editas Medicine stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.